Fiorino Anthony S.
Insider CIK 1608901 · BCLI Chief Executive Officer · IMNP Chief Medical Officer and COO, Director · NAVB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMNPQ IMMUNE PHARMACEUTICALS INC | S Sale | 2020-02-03 | 2020-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy | 2018-05-22 | 2018-05-23 | 25,000 | $0.24 | $6.0K | 75,000 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy | 2018-05-17 | 2018-05-18 | 50,000 | $0.26 | $13.0K | 50,000 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | A Award deriv | 2017-09-14 | 2017-09-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2017-06-30 | 2017-06-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2017-06-30 | 2017-06-30 | 50,000 | — | $0 | 78,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2016-04-20 | 2016-04-29 | 28,000 | — | $0 | 28,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2014-10-15 | 2014-10-15 | 200 | $3.59 | $718 | 2,200 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2014-10-15 | 2014-10-15 | 300 | $3.60 | $1.1K | 2,500 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2014-09-18 | 2014-09-19 | 800 | $3.84 | $3.1K | 2,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2014-09-15 | 2014-09-16 | 5,000 | $0.29 | $1.4K | 15,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2014-09-15 | 2014-09-16 | 3,000 | $0.28 | $840 | 18,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2014-09-12 | 2014-09-16 | 2,500 | $0.28 | $700 | 2,500 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2014-09-12 | 2014-09-16 | 7,500 | $0.29 | $2.2K | 10,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award deriv | 2014-06-09 | 2014-06-10 | 5,700,000 | — | $0 | 5,700,000 | SEC↗ |